FTRE · Fortrea Holdings Inc. · Executive Compensation
$23.77
+0.99 (+4.35%)
At close · Oct 21
Return incl. dividend (before tax)
Market Cap
$2.17B
Shares
95.10M
Volume · Oct 21
471.13K
Avg daily vol (3M)
1.59M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Thomas Pike | Former Chief Executive Officer | $7,791,722 |
| Mark Morais | Chief Operating Officer; President, Clinical Services | $1,616,788 |
| Peter M. Neupert | CEO | $1,145,261 |
| Peter Neupert | Interim Chief Executive Officer | $1,145,261 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Thomas Pike | Chief Executive Officer | $1,713,906 |
| Jill McConnell | Chief Financial Officer | $1,342,017 |
| Mark Morais | Chief Operating Officer; President, Clinical Services | $1,336,761 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Thomas Pike | Chief Executive Officer | $26,320,395 |
| Mark Morais | Chief Operating Officer; President, Clinical Services | $3,230,173 |
| Jill McConnell | Chief Financial Officer | $3,078,795 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Jill McConnell | Chief Financial Officer | $1,075,809 |
| Mark Morais | Chief Operating Officer; President, Clinical Services | $896,351 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Carrie Russell | Chief Accounting Officer | Appointed | 2026-09-30 |
| David Smith | Interim Chief Financial Officer | Resigned | 2026-09-10 |
| David Smith | Interim Chief Financial Officer and principal financial officer | Appointed | 2026-07-29 |
| Carrie Russell | interim principal accounting officer | Appointed | 2026-07-14 |
| Carrie Russell | interim Chief Accounting Officer | Appointed | 2026-07-14 |
| Robert A. Parks | Chief Accounting Officer and principal accounting officer | Resigned | 2026-07-14 |
| Jason F. Knoblauch | Chief Financial Officer | Appointed | 2026-06-26 |
| William J. Sharbaugh | Class III director | Appointed | 2025-09-22 |
| Machelle Sanders | Class II Director | Appointed | 2025-06-12 |
| Erin L. Russell | Class II Director | Appointed | 2025-06-12 |
| Dr. Amrit Ray | Class II Director | Appointed | 2025-06-12 |
| Anshul Thakral | Class III director | Appointed | 2025-06-11 |
| Anshul Thakral | President and Chief Executive Officer | Appointed | 2025-06-11 |
| Peter M. Neupert | Chair of the Board | Appointed | 2025-05-12 |
| Erin L. Russell | Class II director | Appointed | 2025-03-10 |
| Erin L. Russell | independent member of the Company's Board of Directors | Appointed | 2025-02-21 |
| Peter Neupert | Lead Independent Director | Appointed | 2025-02-21 |
| Andrew Eckert | member of the Board | Resigned | 2025-02-21 |
| Robert A. Parks | Chief Accounting Officer | Appointed | 2024-07-11 |
| Machelle Sanders | Class II director | Appointed | 2024-05-16 |
| Amrit Ray M.D. | independent director | Appointed | 2023-07-03 |
| Peter Neupert | independent director | Appointed | 2023-07-03 |
| Ed Pesicka | independent director | Appointed | 2023-07-03 |
| R. Andrew Eckert | Lead Independent Director | Appointed | 2023-07-03 |
| R. Andrew Eckert | Class III Director | Appointed | 2023-07-03 |
Leadership
- Anshul Thakral CEO, Board Member
- Peter M. Neupert CEO, Board Member
- Thomas Pike CEO, Chairman, Board Member
- Jason F. Knoblauch CFO
- Jill McConnell CFO
- Mark Morais COO
- Amanda Warren Chief Accounting Officer
- Carrie Russell Chief Accounting Officer
- Robert A. Parks Chief Accounting Officer
- Amrit Ray Board Member
- Amrit Ray M.D. Board Member
- Betty Larson Board Member
- David Smith Board Member
- Dr. Amrit Ray Board Member
- Ed Pesicka Board Member
- Edward Pesicka Board Member
- Erin L. Russell Board Member
- Machelle Sanders Board Member
- Peter Neupert Board Member
- R. Andrew Eckert Board Member
- William J. Sharbaugh Board Member
- William Sharbaugh Board Member
Key facts
CIK
1965040
CUSIP
34965K107
13F (30d)
34 filings
34 filers
Visit website
Investor relations